16V

3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid

Created:2012-10-24
Last modified:  2013-06-05

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count0
Bond Count39
Aromatic Bond Count11
2D diagram of 16V
Toggle HydrogenToggle Labels

Chemical Component Summary

Name3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid
Systematic Name (OpenEye OEToolkits)3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluoranyl-benzoic acid
FormulaC15 H17 F N2 O3
Molecular Weight292.305
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01O=C(O)c2cc(OCCCc1c(nnc1C)C)c(F)cc2
SMILESCACTVS3.370Cc1[nH]nc(C)c1CCCOc2cc(ccc2F)C(O)=O
SMILESOpenEye OEToolkits1.7.6Cc1c(c(n[nH]1)C)CCCOc2cc(ccc2F)C(=O)O
Canonical SMILESCACTVS3.370 Cc1[nH]nc(C)c1CCCOc2cc(ccc2F)C(O)=O
Canonical SMILESOpenEye OEToolkits1.7.6 Cc1c(c(n[nH]1)C)CCCOc2cc(ccc2F)C(=O)O
InChIInChI1.03 InChI=1S/C15H17FN2O3/c1-9-12(10(2)18-17-9)4-3-7-21-14-8-11(15(19)20)5-6-13(14)16/h5-6,8H,3-4,7H2,1-2H3,(H,17,18)(H,19,20)
InChIKeyInChI1.03 WBFUHHBPNXWNCC-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB17999 
NameAcoramidis
Groups
  • investigational
  • approved
DescriptionAcoramidis is a small molecule stabilizer of transthyretin (TTR) for use in patients with TTR amyloidosis.[L51958] Similar to the previously developed [tafamidis], acoramidis is used to stabilize TTR in its tetrameric form, preventing the formation of amyloidogenic monomers and the progression of amyloidosis.[A264768] Although they share a mechanism of action, acoramidis is more selective for TTR and is a more potent stabilizer when compared to tafamidis.[A264768] Acoramidis has been in development since at least 2013.[A264808] It was brought to market by BridgeBio Pharma and approved by the FDA in November 2024 to reduce negative cardiovascular outcomes in patients with cardiomyopathy caused by TTR amyloidosis.[L51958,L51968]
Synonyms
  • Acoramidis hydrochloride
  • 3-(3-(3,5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid
  • Acoramidis
Brand Names
  • Beyonttra
  • Attruby
IndicationAcoramidis is indicated to reduce cardiovascular death and cardiovascular-related hospitalization in adult patients with cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM).[L51958]
Categories
  • Acids, Carbocyclic
  • Amyloidosis, prevention & control
  • BCRP/ABCG2 Substrates
  • Benzene Derivatives
  • Benzoates
ATC-CodeC01EB25
CAS number1446711-81-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
TransthyretinMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAV...unknownmodulator
UDP-glucuronosyltransferase 1A9MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...unknownsubstrate
UDP-glucuronosyltransferase 1A1MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL...unknownsubstrate
UDP-glucuronosyltransferase 2B7MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL3940890
PubChem 71464713
ChEMBL CHEMBL3940890